Azitra's Grant - III Round

Azitra raised a round of funding on January 15, 2017. Investors include National Science Foundation.

Azitra is developing a recombinant strain of skin-safe bacterium that secrete therapeutic proteins. These proteins are missing from the skin's microbiome when a person suffers from problems like eczem…

Articles about Azitra's Grant - III Round: